To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Autologous whole blood vs. corticosteroids for epicondylopathy and plantar fasciopathy

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
April 2017

Autologous whole blood vs. corticosteroids for epicondylopathy and plantar fasciopathy

Vol: 6| Issue: 4| Number:45| ISSN#: 2564-2537
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A

Autologous whole blood or corticosteroid injections for the treatment of epicondylopathy and plantar fasciopathy? A systematic review and meta-analysis of randomized controlled trials.

Phys Ther Sport. 2016 Nov;22:114-122

Contributing Authors:
K Tsikopoulos A Tsikopoulos K Natsis

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

The present study is a meta-analysis evaluating the efficacy of autologous whole blood (AWB) therapy versus corticosteroid injections in the treatment of epicondylopathy and plantar fasciopathy (PF). The primary outcome was pain relief at 2-6, 8-13, and 24-26 weeks. The authors included a total of 9 RCTs, and found statistically significant results in favour of corticosteroids at 2-6 weeks for pat...

Join the Conversation

Please Login or Join to leave comments.